Syndax Pharmaceuticals (SNDX) FCF Margin Growth (3y) (2018 - 2024)
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) FCF Margin Growth (3y) (2018 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -3,088.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 14,060.00 |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -82,680.00 |
| Sep 30, 2024 | -29,701.00 |
| Jun 30, 2024 | 429,733.00 |
| Dec 31, 2021 | 404,193.00 |
| Sep 30, 2021 | 467,152.00 |
| Jun 30, 2021 | -234,723.00 |
| Mar 31, 2021 | -67,177.00 |
| Dec 31, 2020 | -304,351.00 |
| Sep 30, 2020 | -148,934.00 |
| Jun 30, 2020 | -177,943.00 |
| Mar 31, 2020 | -4,840.00 |
| Dec 31, 2019 | 6,587.00 |
| Sep 30, 2019 | 152,108.00 |
| Jun 30, 2019 | -102,180.00 |
| Mar 31, 2019 | -229,795.00 |
| Dec 31, 2018 | -254,401.00 |
| Sep 30, 2018 | -316,981.00 |
| Jun 30, 2018 | 1.95 Mn |